Top Tweets for #ohemasterclass
Thank you to all of our speakers for their expert contribution to the discussion around the adoption of severity in value assessment, and to our delegates whose thought-provoking questions challenged the thinking in the virtual room! #OHEMasterclass #HealthEconomics #healthpolicy
Chris Skedgel at the Severity in value assessment: from principle to practice 26.05.22 #OHEMasterclass #HealthEconomics #Severity #healthpolicy #ValueAssessment
Dr .@VivianReckers .@ESHPM_EUR, .@EsCHER_EUR shares the Netherlands experiences at Severity in value assessment: from principle to practice Masterclass 26.05.22 #OHEMasterclass #HealthEconomics #Severity #healthpolicy #ValueAssessment
Dr .@VivianReckers .@ESHPM_EUR, .@EsCHER_EUR shares the Netherlands experiences at Severity in value assessment: from principle to practice Masterclass 26.05.22 #OHEMasterclass #HealthEconomics #Severity #healthpolicy #ValueAssessment
We’re looking forward to our first 2022 Masterclass on Severity in Value Assessment. We’ll be live Tweeting from 14:00 BST today, stay tuned for highlights and insights from all our expert speakers #OHEMasterclass #HealthEconomics #Severity #healthpolicy https://t.co/83LBPAfNlp
Have you been following today’s Masterclass and wanting to get involved? The OHE Masterclass series will return and explore a new theme in early 2022. In the meantime, you are able to access all the 2021 Masterclasses on-demand. Email [email protected] for enquires.
#OHEMasterclass
Martina Garau @martinagarau09 summarises key learnings of today’s Innovation for Small Population Masterclass –#OHEMasterclass #Healtheconomics #rarediseases #healthpolicy
Jorge Mestre Ferrandiz reveals that relative spending on OMPs have increased over the last 20 years which may reflect a shift towards expenditure in higher cost, lower volume patient populations.
#OHEMasterclass #Healtheconomics
Adrian Towse, OHE, highlights that the cost associated with R&D of OMPs are less than non-OMPs due to better scientific success. #OHEMasterclass #Healtheconomics #raredisease #R&D #orphanmedicinalproducts
Fleur Chandler, Project HERCULES, ‘Project HERCULES’ success is due largely to patient-led expertise’ @fleurchy @DuchenneUK
#OHEMasterclass #Healtheconomics #paediatric #raredisease #DuchenneMuscularDystrophy
Mike Drummond, University of York, reflects that in the absence of disease-specific PROMs, interpretation of the impacts on QoL needs inputs from patients and clinicians #OHEMasterclass #Healtheconomics #orphandrugs #rarediseases
Mike Drummond, University of York, highlights that QALYs have both theoretical and practical shortcomings in appraising rare disease treatments #OHEMasterclass #Healtheconomics
The Innovation for Small Populations Masterclass is under way! We have brought together global thought leaders to discuss how we can tackle the challenges associated with developing interventions for rare conditions. #OHEMasterclass #Healtheconomics #SmallPopulations #treatments
We’re ready for our fifth and final Masterclass in the Demonstrating Value Series. We’ll be live posting from 14:00 this afternoon- stay tuned for highlights and insights from all our expert speakers #OHEMasterclass #HealthEconomics #SmallPopulations #rarediseases #healthpolicy
Thank you to all of today’s speakers for their expert contribution to the debate on how to make adaptive pathways work in the HTA context, and to our delegates whose thought-provoking questions challenged the thinking in the virtual room #OHEMasterclass #HealthEconomics
#1 Reflecting on today's insights - Adaptive pathways are used to balance patient access with evidence development for promising innovative therapies... #OHEMasterclass #HealthEconomics #AdaptivePathways #EarlyAccess
Adrian Towse, OHE, is kicking off his session considering the implications of accelerated approval for payer uncertainty around the expected outcomes from treatment and likely cost-effectiveness at the point at which payers and HTA bodies consider reimbursement #OHEMasterclass
The first panel is well underway! A key takeaway from our experts who are exploring the prospects of adaptive pathways: opportunities in US differ significantly from EU where early dialogue between regulatory, HTA and manufacturers is increasingly well-coordinated #OHEMasterclass
We are ready to kick off our Adaptive Pathways Masterclass - stick with us until 17:30 for all the highlights and insights for today's event #OHEMasterclass #HealthEconomics #AdaptivePathways #EalryAccess
Our panel is tackling excellent questions from our international audience, offering their insights and expertise to the challenges surrounding patient preferences #OHEMasterclass #healtheconomics
Last Seen Hashtags on Sotwe
bbc mom
Seen from Malaysia
bokep indo
Seen from Indonesia
自作OS
Seen from United States
cuckcum
Seen from United States
自己満足のﾍﾞｽﾄｼｮｯﾄを晒せ
Seen from United States
public masturbate+video
Seen from Korea
snapchat
Seen from United States
樹液採集個体
Seen from United States
türkporno
Seen from Turkey
minichat video
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers